Johnson & Johnson is investing over $1 billion to construct a new cell therapy plant in Lower Gwynedd Township, Montgomery County, which will create approximately 500 jobs over the next 12 years. This expansion will enhance J&J’s manufacturing capabilities for cancer and autoimmune disease treatments and further solidifies its presence in the Philadelphia region. The state of Pennsylvania has pledged $41.5 million in support for the project, with construction expected to begin later this year and the plant operational by the end of 2031.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
J&J to invest $1B in new Montgomery County cell therapy plant
Johnson & Johnson is investing over $1 billion to construct a new cell therapy plant in Lower Gwynedd Township, Montgomery County, which will create approximately 500 jobs over the next 12 years. This expansion will enhance J&J’s manufacturing capabilities for cancer and autoimmune disease treatments and further solidifies its presence in the Philadelphia region. The state of Pennsylvania has pledged $41.5 million in support for the project, with construction expected to begin later this year and the plant operational by the end of 2031.